Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Guggenheim Spin-Off ETF (CSD)

Delayed Data
As of Nov 25
 +0.41 / +1.01%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks investment results that correspond generally to the performance, before the fund's fees and expenses, of an equity index called the Beacon Spin-Off Index. The fund will invest at least 90% of its assets in common stock, ADRs and MLPs that comprise the index and depositary receipts representing common stocks included in the index. The Spin-Off Index was comprised of approximately 25 securities selected, based on investment and other criteria, from a broad universe of U.S.-traded stocks, American depositary receipts ("ADRs") and master limited partnerships ("MLPs"). The fund is non-diversified.

No recent news for Guggenheim Spin-Off ETF.


1 month+0.15% 3 years+14.01%
3 months+6.07% 5 years+14.05%
1 year-10.46% Since inception+6.75%
Data through 11/26/2015

Quote Details

Previous close$40.63
Open day’s range40.59 – 41.09
Net asset value (NAV)41.05 (11/25/2015)
Daily volume72,876
Average volume (3 months)67,655
Data as of 3:58pm ET, 11/25/2015

Peer Comparisonvs. Mid-cap blend ETFs

Performance 5-yr return+14.05%+12.76%
Expense Gross exp ratio0.72%0.46%
Risk 5 year sharpe ratio0.970.94
Net assets$377.3M$2.7B
Average market cap$4.0B$6.6B
Average P/E16.118.1
Dividend / Share--0.24%


VO Vanguard Mid-Cap Index Fund ETF Shares
TTFS AdvisorShares TrimTabs Float Shrink ETF
IWR iShares Russell Mid-Cap ETF


Top 5 Sectors
Portfolio weighting
Consumer goods 22.61%
Media 15.06%
Financial service 12.82%
Business service 12.57%
Telecommunication 9.64%
Top 10 Holdings
Portfolio weighting
BPY Brookfield Property Partners LP5.52%
ALLE Allegion PLC5.47%
LMCA Liberty Media Corp5.45%
NWSA News Corp5.33%
KEYS Keysight Technologies Inc5.23%
ABBV AbbVie4.59%
ZTS Zoetis Inc4.57%
WWAV WhiteWave Foods Co4.56%
NRZ New Residential Investment Corp3.67%
MUSA Murphy USA Inc3.66%